Expression of Ang-2/Tie-2 and PI3K/AKT in Colorectal Cancer

  • Published : 2014.11.06


Purpose: To study the expression of angiogenin-2 (Ang-2) and its receptor Tie-2 in colorectal cancer and discuss the possible mechanisms behind this process. Materials and Methods: Using the streptavidin-peroxidase (SP) immunohistochemical method, paraffin sections from 100 colorectal cancer samples and 10 samples from tumor-adjacent normal tissue (> 2 cm from the edge of the gross tumor) were tested for protein expression of Ang-2, Tie-2, PI3K, and AKT. Reverse transcription-polymerase chain reaction and Western blots were further used to measure expression of the 4 genes and proteins in 20 freshly-resected colorectal cancer samples and tumor-adjacent normal tissues. Results: In colorectal cancer tissues, the expression of the Ang-2, Tie-2, PI3K, and AKT genes and their proteins was significantly higher than in tumor-adjacent normal tissues. Protein expression in poorly-differentiated adenocarcinoma was higher than that in well and moderately differentiated adenocarcinoma. According to Duke's classification, the protein expression in Stages C and D was significantly higher than that in Stages A and B. In the group with lymphatic metastasis, the protein expression was higher than that without lymphatic metastasis. Conclusions: In colorectal cancer, the expression of the Ang-2, Tie-2, PI3K, and AKT genes and their proteins is markedly higher than those in tumor-adjacent normal tissues. No correlation was observed between protein expression and gender, location, or histologic type. Correlations did exist between protein expression and differentiation level, stage of Duke's classification, and lymphatic metastasis; in colorectal cancer tissues with lower differentiation levels, higher stages of Duke's classification, and lymphatic metastasis, the expression of all 4 proteins was higher. The study of their expression patterns and relationships with aggression and metastasis will provide a valuable experimental foundation for assessing prognosis and targeted therapy of colorectal cancer.


  1. Gao D, Inuzuka H, Tseng A, et al (2009). Phosphorylation by AKT1 promotes cytoplasmic localization of Skp2 and impairs APC-Cdhl-medi-ated Skp2 destruction, Nat Cell Biol, 11, 397-408.
  2. Abubaker J, Bavi P, Al-Harbi S, et al (2008). Mutation of the PIK3CA oncogene in human cancers. Oncogene, 27, 3539-45.
  3. Cao YT, Sonveaux P, Liu SL, et al (2007). Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth. Cancer Res, 67, 3835-44.
  4. Chen X, Liao J, Lu Y, et al (2011). Activation of the PI3K/AKT pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells panc-1. Pathol Oncol Res, 17, 257-61.
  5. Coelho RP, Yuelling LM, Fuss B, Sato-Bigbee C (2009). Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes. Glia, 57, 1754-64.
  6. De Palma M, Naldini L (2011). Angiopoietin-2 TIEs up macrophages in tumor angiogenesis. Clin Cancer Res, 17, 5226-32.
  7. Goede V, Coutelle O, Neuneier J, et al (2010). Identification of serum angiopoietin -2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumabcontaining therapy. Br J Cancer, 103, 1407-14.
  8. Hu KJ (2009). The relationship between Ang-1, Ang-2 expression and NPC lymphatic metastasis and in vitro experiment on the PDT's effect suppressing lymphatic metastasis [D] Hunan: Central South Univ.
  9. Huang C, Li J, Ma TT (2011). PI3K/Akt signaling pathway and liver fibrosis. Chin Pharmacol Bull, 27, 1037-41.
  10. Johnson SM, Gulhati P, Rampy BA, et al (2010). Novel expression patterns of PI3K/AKT/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg, 210, 767-78
  11. Kang MH, Kim JS, Seo JE, et al (2010). BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Exp Cell Res, 316, 24-37.
  12. Mazzieri R, Pucci F, Moi D, et al (2011). Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell, 19, 512-26.
  13. Li HY, Zhang Y, Cai JH, et al (2013). MicroRNA-451 inhibits growth of human colorectal carcinoma cells via downregulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev, 14, 3631-4.
  14. Lin DX, Lin YC (2008). Angiogenin in tumor. Medical Recapitulate, 14, 535-6.
  15. Lin HK, Wang G, Chen Z, et al (2009). Phosphorylationdependent regulation of cytosolic localization and oncogenic function of Skp2 by AKT/PKB. Nat Cell Biol, 11, 420-32.
  16. Pohl J, Nguyen-Tat M, Pech O, et al (2008). Computed virtual chromoendoscopy for classification of small colorectal lesions:a prospective comparative study. Am J Gastroenterol, 103, 562-9.
  17. Sarraf-Yazdi S, Mi J, Moeller BJ, et al (2008). Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer. J Surg Res, 146, 16-23.
  18. Seval Y, Sati L, Celik-Ozenci C, et al (2008). The distribution of angiopoietin-l,angiopoietin -2 and their receptors Tie-1 and Tie-2 in the very early human placenta. Placenta, 29, 809-15.
  19. Sheng SJ, Qiao M, Pardee AB (2009). Metastasis and AKT activation. J Cell Physiol, 121, 451-4.
  20. Sun Y, Liu JH, Pan L, et al (2011). Modulatory effects of Beclin 1 on expression of angiopoietin and Tie-2 receptor in human cervical cancer cells. Asian Pac J Cancer Prev, 12, 2985-90.
  21. Wang HL, Deng CS, Lin J, et al (2007). Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenocarcinoma. Tohoku J Exp Med, 213, 33-40.
  22. Yap TA, Garrett MD, Walton MI, et al (2008). Workman, targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises [J]. Curr Opin Pharmacol, 8, 393-412.
  23. Zhou Q, Guo P, Gallo JM (2008). Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clin Cancer Res, 14, 1540-9.

Cited by

  1. MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras vol.55, pp.9, 2015,